Judith‐Anne W. Chapman

Author

Also Known As

Donald A Berry, J W Chapman, J. W. Chapman, J.W. Chapman, Judith-Anne W Chapman, Judith-Anne W. Chapman, Judith‐Anne W. Chapman, L E Shepherd, Pritchard, Kathleen I., Scher, Judite

Publications

954

Citations

H-Index

Concepts

All Affiliations

University of Toronto Queen's University Sunnybrook Health Science Centre BC Cancer Agency McMaster University

About

Judith‐Anne W. Chapman is an author at University of Toronto specializing in oncology, medicine, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	210
2	Health Sciences	3	3	199
3	Pathology	2	2	163
4	Engineering	1	1	11
5	Biostatistics	1	1	11

Judith‐Anne W. Chapman

Publications

828

Citations

H-Index

Page 1

	Year	Citations
Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31 Karen A. Gelmon, Frances Boyle, Bella Kaufman, Journal of Clinical Oncology	2015	183
Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer Margot J. Burnell, Mark N. Levine, Judith‐Anne W. Chapman, Journal of Clinical Oncology Surgical OncologyBreast OncologyCancer ManagementPaclitaxel Versus DoxorubicinPathology	2009	152
Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14 Kathleen I. Pritchard, Lois E. Shepherd, Judith‐Anne W. Chapman, Journal of Clinical Oncology	2011	85
Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial Vered Stearns, Judith‐Anne W. Chapman, X. Cynthia, Journal of Clinical Oncology	2014	42
Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial Vivien Bramwell, Alan B. Tuck, Judith‐Anne W. Chapman, Breast Cancer Research	2014	42
Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment Judith‐Anne W. Chapman, Naomi Miller, H. Lavina A. Lickley, BMC Cancer	2007	35
Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer Jinani Jayasekera, Clyde B. Schechter, Joseph A. Sparano, JNCI Journal of the National Cancer Institute	2018	34
Effect of Quantitative Nuclear Image Features on Recurrence of Ductal Carcinoma <i>In Situ</i> (DCIS) of the Breast David Axelrod, Naomi Miller, H. Lavina A. Lickley, Cancer Informatics	2008	33
A Comparison of the <i>X</i> <sup>2</sup> , −2 Log <i>R</i> , and Multinomial Probability Criteria for Significance Tests When Expected Frequencies are Small Judith‐Anne W. Chapman Journal of the American Statistical Association	1976	31
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials Rinat Yerushalmi, Bin Dong, Judith‐Anne W. Chapman, Annals of Oncology ObesityBreast OncologyBaseline BmiMedicineWeight Management	2017	31

Page 1